Revisiting Ocular Allergy: Evaluating Symptoms, Benzalkonium Chloride and Efficacy of Topical Ketotifen 0.025

Ocular Immunology and Inflammation
Kostas G BoboridisAnastasios Gp Konstas

Abstract

This interesting study raises a scientific issue for revisiting three important elements on diagnosis, use of preservatives and selection of the appropriate topical treatment. Itchy feeling can be encountered in other ophthalmic conditions misdiagnosed as allergy, benzalkonium chloride is responsible for surface toxicity resulting in reduced efficacy and tolerability of topical allergy medications and it should be avoided on the management of ocular allergy. Unpreserved ketotifen 0,025% has been shown to be the least toxic formulation being the optimum option for efficacy and tolerability on the management of ocular allergy.

References

May 31, 2018·Expert Opinion on Pharmacotherapy·Konstadinos G Boboridis, Anastasios G P Konstas

❮ Previous
Next ❯

Citations

Feb 23, 2020·International Forum of Allergy & Rhinology·Vasiliki TriantafillouJohn V Bosso
Feb 28, 2020·Oxidative Medicine and Cellular Longevity·Anton G RogovRenata A Zvyagilskaya
Oct 23, 2020·Ophthalmology and Therapy·Mohamud A VerjeeChristopher E Starr
Mar 4, 2021·Expert Opinion on Drug Delivery·Gábor HollóAnastasios G Konstas
Jul 16, 2021·Eye·Michael H GoldsteinSrilatha Vantipalli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.